- Home
- FPI vs PHAR Comparison
FPI vs PHAR Comparison
Compare FPI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPI
- PHAR
- Stock Information
- Founded
- FPI 2013
- PHAR 1988
- Country
- FPI United States
- PHAR Netherlands
- Employees
- FPI N/A
- PHAR N/A
- Industry
- FPI Real Estate Investment Trusts
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- FPI Real Estate
- PHAR Health Care
- Exchange
- FPI Nasdaq
- PHAR Nasdaq
- Market Cap
- FPI 607.9M
- PHAR 618.3M
- IPO Year
- FPI 2014
- PHAR N/A
- Fundamental
- Price
- FPI $11.59
- PHAR $8.20
- Analyst Decision
- FPI
- PHAR Strong Buy
- Analyst Count
- FPI 0
- PHAR 3
- Target Price
- FPI N/A
- PHAR $27.00
- AVG Volume (30 Days)
- FPI 241.0K
- PHAR 5.6K
- Earning Date
- FPI 02-26-2025
- PHAR 03-13-2025
- Dividend Yield
- FPI 11.97%
- PHAR N/A
- EPS Growth
- FPI N/A
- PHAR N/A
- EPS
- FPI 0.32
- PHAR N/A
- Revenue
- FPI $58,465,000.00
- PHAR $285,745,000.00
- Revenue This Year
- FPI N/A
- PHAR $20.08
- Revenue Next Year
- FPI N/A
- PHAR $9.22
- P/E Ratio
- FPI $36.15
- PHAR N/A
- Revenue Growth
- FPI 1.30
- PHAR 30.64
- 52 Week Low
- FPI $9.70
- PHAR $6.65
- 52 Week High
- FPI $12.85
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- FPI 46.75
- PHAR 36.29
- Support Level
- FPI $11.46
- PHAR $8.49
- Resistance Level
- FPI $11.82
- PHAR $9.35
- Average True Range (ATR)
- FPI 0.21
- PHAR 0.55
- MACD
- FPI 0.02
- PHAR -0.17
- Stochastic Oscillator
- FPI 46.43
- PHAR 12.14
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.